Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis
Related Experiment Video
Updated: Oct 24, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
G J Griffiths1, L Dubrez, C P Morgan
1Cancer Research Campaign Molecular and Cellular Pharmacology Group, School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom.
Abstract:
Investigation of events committing cells to death revealed that a concealed NH2-terminal epitope of the pro-apoptotic protein Bak became exposed in vivo before apoptosis. This occurred after treatment of human Jurkat or CEM-C7A T-lymphoma cells with the mechanistically disparate agents staurosporine, etoposide or dexamethasone. The rapid, up to 10-fold increase in Bak-associated immunofluorescence was measured with epitope-specific monoclonal antibodies using flow cytometry and microscopy. In contrast, using a polyclonal antibody to Bak, immunofluorescence was detected both before and after treatment. There were no differences in Bak protein content nor in subcellular location before or after treatment. Immunofluorescence showed Bcl-xL and Bak were largely associated with mitochondria and in untreated cells they coimmunoprecipitated in the presence of nonioinic detergent. This association was significantly decreased after cell perturbation suggesting that Bcl-xL dissociation from Bak occurred on exposure of Bak's NH2 terminus. Multiple forms of Bak protein were observed by two dimensional electrophoresis but these were unchanged by inducers of apoptosis. This indicated that integration of cellular damage signals did not take place directly on the Bak protein. Release of proteins, including Bcl-xL, from Bak is suggested to be an important event in commitment to death.
Insights
The pro-apoptotic protein Bak
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Cell death, or apoptosis, is a critical biological process.
- The pro-apoptotic protein Bak plays a key role in initiating apoptosis.
- Understanding the regulation of Bak activation is crucial for cancer research and therapy.
Purpose of the Study:
- To investigate the early events in Bak activation preceding apoptosis.
- To determine the changes in Bak protein conformation and its interaction with other proteins during apoptosis induction.
Main Methods:
- Utilized human T-lymphoma cell lines (Jurkat, CEM-C7A) treated with apoptosis-inducing agents (staurosporine, etoposide, dexamethasone).
- Employed flow cytometry and microscopy with epitope-specific monoclonal antibodies to detect Bak exposure.
- Performed co-immunoprecipitation assays to analyze protein interactions and 2D electrophoresis to examine protein forms.
Main Results:
- A previously hidden NH2-terminal epitope on Bak became exposed before apoptosis, indicated by increased immunofluorescence.
- Bak protein levels and subcellular localization remained unchanged, suggesting conformational changes rather than synthesis or translocation.
- The association between Bak and Bcl-xL at the mitochondria decreased upon cell perturbation, correlating with Bak's NH2-terminal exposure.
Conclusions:
- The exposure of Bak's NH2 terminus is an early event in the commitment to apoptosis.
- Dissociation of Bcl-xL from Bak is linked to this conformational change and may be a critical step in apoptosis.
- Apoptotic signaling does not appear to directly modify Bak protein forms but rather triggers conformational changes and protein interactions.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Caspases
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...

